187 related articles for article (PubMed ID: 15621902)
1. Deep vein thrombosis after total hip arthroplasty in Indian patients with and without enoxaparin.
Jain V; Dhal AK; Dhaon BK; Pradhan G
J Orthop Surg (Hong Kong); 2004 Dec; 12(2):173-7. PubMed ID: 15621902
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
[TBL] [Abstract][Full Text] [Related]
4. Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty: a retrospective analysis.
Krotenberg R; Adler U; Pomeranz B; Miller JD; Russell MW
Am J Phys Med Rehabil; 2001 Dec; 80(12):889-95. PubMed ID: 11821667
[TBL] [Abstract][Full Text] [Related]
5. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
Özler T; Uluçay Ç; Önal A; Altıntaş F
Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
Bara L; Planes A; Samama MM
Br J Haematol; 1999 Feb; 104(2):230-40. PubMed ID: 10050702
[TBL] [Abstract][Full Text] [Related]
7. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
Eriksson BI; Wille-Jørgensen P; Kälebo P; Mouret P; Rosencher N; Bösch P; Baur M; Ekman S; Bach D; Lindbratt S; Close P
N Engl J Med; 1997 Nov; 337(19):1329-35. PubMed ID: 9358126
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
Wade WE
Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis.
Stannard JP; Lopez-Ben RR; Volgas DA; Anderson ER; Busbee M; Karr DK; McGwin GR; Alonso JE
J Bone Joint Surg Am; 2006 Feb; 88(2):261-6. PubMed ID: 16452735
[TBL] [Abstract][Full Text] [Related]
11. Proximal deep vein thrombosis after hip replacement for oncologic indications.
Nathan SS; Simmons KA; Lin PP; Hann LE; Morris CD; Athanasian EA; Boland PJ; Healey JH
J Bone Joint Surg Am; 2006 May; 88(5):1066-70. PubMed ID: 16651581
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
Colwell CW; Spiro TE
Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
[TBL] [Abstract][Full Text] [Related]
13. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
14. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
Superficial Thrombophlebitis Treated By Enoxaparin Study Group
Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
[TBL] [Abstract][Full Text] [Related]
15. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Yamaguchi T; Hasegawa M; Niimi R; Sudo A
Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
Gelfer Y; Tavor H; Oron A; Peer A; Halperin N; Robinson D
J Arthroplasty; 2006 Feb; 21(2):206-14. PubMed ID: 16520208
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
18. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
19. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
Ishibe M; Kariya S
Hip Int; 2011; 21(6):684-7. PubMed ID: 22101618
[TBL] [Abstract][Full Text] [Related]
20. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
Ennis RS
J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
